A carregar...
SARS‐CoV‐2 (COVID‐19) vaccination in dermatology patients on immunomodulatory and biologic agents: Recommendations from the Australasian Medical Dermatology Group
As the phase III COVID‐19 vaccine trials excluded patients on immunosuppressive treatments, or patients with significant autoimmunity, the Australasian Medical Dermatology Group make the following preliminary recommendations around COVID‐19 vaccination in dermatology patients on immunomodulatory and...
Na minha lista:
| Publicado no: | Australas J Dermatol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8250550/ https://ncbi.nlm.nih.gov/pubmed/33786833 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajd.13593 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|